Applied Therapeutics
Stock Forecast, Prediction & Price Target
Applied Therapeutics (APLT) stock Price Target by analysts
$4.5
Potential upside: 811.30%
Applied Therapeutics price prediction
What is Applied Therapeutics stock analysts` prediction?
Applied Therapeutics stock forecast: Based on 2 Wall Street analysts` predicted price targets for Applied Therapeutics in the last 3 months, the avarage price target is $4.5, with a high forecast of $NaN. The average price target represents a 811.30% change from the last price of $0.49.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Applied Therapeutics stock Price Target by analysts
Full breakdown of analysts given Applied Therapeutics price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Brian Abrahams RBC Capital | 0% 0/1 | 10 months ago | $4 710.04% upside | $9.42 | StreetInsider | Previous targets (0) |
Brian Skorney Robert W. Baird | 0% 0/1 | 10 months ago | $5 912.55% upside | $9.42 | StreetInsider | Previous targets (0) |
Applied Therapeutics Financial Estimates
Applied Therapeutics Revenue Estimates
Applied Therapeutics EBITDA Estimates
Applied Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $9.99M 0% | Avg: $45.65M Low: $28.61M High: $65.90M avg. 356.90% | Avg: $131.41M Low: $82.35M High: $189.68M avg. 187.82% | Avg: $276.75M Low: $173.43M High: $399.46M avg. 110.59% | Avg: $388.77M Low: $243.63M High: $561.15M avg. 40.47% |
Net Income
% change YoY
| $-104.61M N/A | $-81.68M 21.91% | $-119.76M -46.60% | Avg: $-52.51M Low: $-58.73M High: $-20.21M avg. 56.14% | Avg: $34.01M Low: $-15.35M High: $25.08M avg. 164.77% | Avg: $44.64M Low: $22.97M High: $70.38M avg. 31.24% | Avg: $90.14M Low: $46.39M High: $142.10M avg. 101.88% |
EBITDA
% change YoY
| $-105.61M N/A | $-82.88M 21.52% | $-64.53M 22.13% | Avg: $27.39M Low: $17.16M High: $39.54M avg. 142.44% | Avg: $78.84M Low: $49.41M High: $113.81M avg. 187.82% | Avg: $166.05M Low: $104.06M High: $239.68M avg. 110.59% | Avg: $233.26M Low: $146.18M High: $336.69M avg. 40.47% |
EPS
% change YoY
| -$4.09 N/A | -$2.16 47.18% | -$1.42 34.25% | Avg: -$0.45 Low: -$0.7 High: -$0.24 avg. 68.01% | Avg: $0.06 Low: -$0.18 High: $0.3 avg. 112.71% | Avg: $0.53 Low: $0.27 High: $0.84 avg. 817.90% | Avg: $1.07 Low: $0.55 High: $1.69 avg. 101.88% |
Operating Expenses
% change YoY
| $105.61M N/A | $82.95M -21.46% | $74.52M -10.15% | Avg: $55.04M Low: $34.49M High: $79.45M avg. -26.13% | Avg: $158.44M Low: $99.29M High: $228.69M avg. 187.82% | Avg: $333.68M Low: $209.10M High: $481.63M avg. 110.59% | Avg: $468.74M Low: $293.74M High: $676.57M avg. 40.47% |
FAQ
What is Applied Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 88.51% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -58.73M, average is -52.51M and high is -20.21M.
What is Applied Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 173.94% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $28.61M, average is $45.65M and high is $65.90M.
What is Applied Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 275.13% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.7, average is -$0.45 and high is $-0.24.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Applied Therapeutics stock. The most successful analyst is Brian Abrahams.